Related Experiment Video
Updated: Jun 12, 2026

Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes
Published on: March 3, 2023
Vision therapy/orthoptics for symptomatic convergence insufficiency in children: treatment kinetics
Mitchell Scheiman1, Marjean Taylor Kulp, Susan Cotter
1Pennsylvania College of Optometry, Salus University, Elkins Park, Pennsylvania 19141, USA. mscheiman@salus.edu
Insights
Office-based vergence/accommodative therapy (OBVAT) offers faster symptom and sign improvement for convergence insufficiency (CI) in children. This vision therapy regimen leads to better outcomes compared to home-based or placebo treatments.
Area of Science:
- Ophthalmology
- Optometry
- Pediatric Vision
Background:
- Convergence insufficiency (CI) is a common binocular vision disorder affecting children.
- Effective treatment is crucial for visual comfort and academic performance.
Purpose of the Study:
- To compare the effectiveness of different vision therapy regimens for treating symptomatic CI in children.
- To evaluate the kinetics of symptom and sign changes over 12 weeks of treatment.
Main Methods:
- A randomized clinical trial involving 221 children (aged 9-17) with symptomatic CI.
- Comparison of home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy plus pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), and office-based placebo therapy (OBPT).
- Outcome measures included the CI Symptom Survey (CISS), near point of convergence (NPC), and positive fusional vergence (PFV) at 4, 8, and 12 weeks.
Main Results:
- The OBVAT group showed significant symptom improvement at each visit, unlike other groups.
- All groups improved between weeks 8 and 12, but OBVAT had fewer symptoms by week 8.
- OBVAT demonstrated the most significant improvements in NPC and PFV, particularly within the first 4 weeks, and continued to improve PFV at weeks 8 and 12.
Conclusions:
- Clinical signs (NPC, PFV) improve faster than symptoms in children treated for CI.
- OBVAT is superior to HBPP, HBCVAT+, and OBPT in accelerating symptom and sign improvement and achieving treatment success criteria.
Purpose:
To evaluate the kinetics of change in symptoms and signs of convergence insufficiency (CI) during 12 weeks of treatment with commonly prescribed vision therapy/orthoptic treatment regimens.
Methods:
In a randomized clinical trial, 221 children aged 9 to 17 years with symptomatic CI were assigned to home-based pencil push-ups (HBPP), home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+), office-based vergence/accommodative therapy with home reinforcement (OBVAT), or office-based placebo therapy with home reinforcement (OBPT). Symptoms and signs were measured after 4, 8, and 12 weeks of treatment. The outcome measures were the mean CI Symptom Survey (CISS), near point of convergence (NPC), positive fusional vergence (PFV), and proportions of patients who were classified as successful or improved based on a composite measure of CISS, NPC, and PFV.
Results:
Only the OBVAT group showed significant improvements in symptoms between each visit (p < 0.001). Between weeks 8 and 12, all groups showed a significant improvement in symptoms. Between-group differences were apparent by week 8 (p = 0.037) with the fewest symptoms in the OBVAT group. For each group, the greatest improvements in NPC and PFV were achieved during the first 4 weeks. Differences between groups became apparent by week 4 (p < 0.001), with the greatest improvements in NPC and PFV in the OBVAT group. Only the OBVAT group continued to show significant improvements in PFV at weeks 8 and 12. The percentage of patients classified as "successful" or "improved" based on our composite measure increased in all groups at each visit.
Conclusions:
The rate of improvement is more rapid for clinical signs (NPC and PFV) than for symptoms in children undergoing treatment for CI. OBVAT results in a more rapid improvement in symptoms, NPC and PFV, and a greater percentage of patients reaching pre-determined criteria of success when compared with HBPP, HBCVAT+, or OBPT.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Focusing of Light in the Eye
Glaucoma: Overview
